Product
CL-108
1 clinical trial
3 indications
Indication
PainIndication
NauseaIndication
VomitingClinical trial
A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg (Hydrocodone 5 mg/Acetaminophen 325 mg/Promethazine 12.5 mg) as a Treatment for Moderate-to-Severe Acute Pain and the Prevention of Opioid-Induced Nausea and Vomiting (OINV) Following Orthopedic SurgeryStatus: Completed, Estimated PCD: 2018-04-16